THOMAS SKINNER: Open Payments
NPI 1144620113 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 29 payments from 10 companies in 2025. Trend: 2023 $1,278 · 2024 $896 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $273 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $136 |
| Actelion Pharmaceuticals US, Inc. | 1 | $133 |
| Vital Connect, Inc | 1 | $112 |
| PFIZER INC. | 5 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $26 |
| United Therapeutics Corporation | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: Repatha, Kerendia, UPTRAVI, VITALPATCH RTM, VYNDAQEL, JARDIANCE, ELIQUIS, LifeVest.
Industry payments across AL — which companies pay providers there.
